drugset / Trial / NCT03722927

The Use Of Liposomal Bupivacaine For Pain Control

NCT03722927 ↗

Phase 4 Completed 3 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this research study is to determine how well the local anesthetic, liposomal bupivacaine, controls postoperative pain after mastectomy and breast reconstruction.

Timeline

Start
2018-06-14
Primary completion
2020-01-29
Completion
2020-01-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 60 ml Other
Subject Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.